Moderna Announces Coronavirus Vaccine With 95.5% Success Rate

Moderna Announces Coronavirus Vaccine With 94.5% Success Rate

Moderna Inc. claims that its COVID-19 vaccine is 94.5% effective—a higher rate than Pfizer’s vaccine.

  • By Nikki Johnson-Bolden
  • Nov 17, 2020

Biotech company Moderna Inc. announced on November 16 that the coronavirus vaccine it has developed is 94.5% effective, according to NPR.

This information arrives on the heels of a new record number of coronavirus cases. As of November 15, there are more than 11 million confirmed COVID-19 cases in the United States. Johns Hopkins’ COVID-19 tracker reports 166,55 new cases and 1,266 new deaths. This new peak occurs just six days after the U.S. reached 10 million coronavirus cases.

This is the second vaccine of nearly 100% effectiveness to emerge—last week, Pfizer announced its own vaccine with a 90% rate of effectiveness.

Moderna will file for emergency use authorization from the FDA for the vaccine within the next few weeks. The company expects to ship 20 million doses of the vaccine in the United States by the end of this year.

About the Author

Nikki Johnson-Bolden is an Associate Content Editor for Occupational Health & Safety.

Product Showcase

  • NoiseCHEK Personal Noise Dosimeter

    SKC NoiseCHEK is the easiest-to-use dosimeter available! Designed specifically for OEHS professionals, SKC NoiseCHEK offers the easiest operation and accurate noise measurements. Everything you need is right in your palm. Pair Bluetooth models to your mobile devices and monitor workers remotely with the SmartWave dB app without interrupting workflow. Careful design features like a locking windscreen, sturdy clip, large front-lit display, bright status LEDs, and more make NoiseCHEK the top choice in noise dosimeters. Demo NoiseCHEK at AIHA Connect Booth 1003. Read More

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" Read More

  • Glove Guard® Clip

    Safety should never be compromised, especially when it comes to proper glove usage. The Glove Guard® clip enhances safety by encouraging employees to keep their gloves with them at all times. This reduces the risk of accidents and injuries on the job. By ensuring everyone has their gloves readily available, we help promote a culture of safety and efficiency. The Glove Guard® clip is designed to withstand the toughest work environments. Constructed from robust materials made in the USA, it can endure extreme conditions, including harsh weather, and rigorous activities. Read More

Featured

Most   Popular

Artificial Intelligence